Can decision analytic modelling promote clinical translation of personalised medicine markers for oncology drugs?

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1028492

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Personalised medicine is an approach that has great potential to improve healthcare. There has been limited success to date, however, in utilising proposed tests in the clinical. It is proposed that use of mathematical models early in the development of personalised medicine tests will allow early understanding of the value that the test will have for patients and society. Such insight will help build a strong case to undertake the research required before personalised medicine can be more widely used to improve treatment for cancer.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $69,893.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pharmacogenomics

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer prognosis | cancer therapy | health economics | pharmacogenetics | pharmacogenomics

Related Links